Medicare will soon cover a new class of Alzheimer's drugs if they receive full approval from the U.S. Food and Drug Administration, with some key limits.
Jun 2, 2023
0
14
The Food and Drug Administration (FDA) in the U.S. has authorized the first approved drug for a rare form of motor neuron disease (MND) based on the results of a Phase 3 clinical trial completed at the University of Sheffield, ...
May 1, 2023
0
7
U.S. health officials on Wednesday approved the first pill made from healthy bacteria found in human waste to fight dangerous gut infections—an easier way of performing so-called fecal transplants.
Apr 27, 2023
0
5
The Food and Drug Administration (FDA) approved Narcan, 4 milligram (mg) nasal spray for over-the-counter sale. Narcan is a nasal spray version of naloxone, a rescue medicine that can be administered in the event of an opioid ...
Mar 30, 2023
0
2
The U.S. Food and Drug Administration on Wednesday approved the over-the-counter use of a nasal spray that can reverse an opioid overdose.
Mar 29, 2023
0
2
Excitement is building about a new generation of drugs that tout the ability to help adults with excess weight shed more pounds than older drugs on the market.
Oct 20, 2022
0
3
Expected to be diagnosed in 2% of men and 1% of women in the U.S., kidney cancer has traditionally been one of the most challenging cancers to treat. Until 2005, only one drug had been approved by the Food and Drug Administration ...
Oct 14, 2022
0
4
Partner companies Eisai and Biogen recently announced promising clinical trial results for their new Alzheimer's drug lecanemab. Over 18 months, patients treated with lecanemab experienced slower symptom progression than ...
Oct 14, 2022
0
5
Patients arriving at Dr. Philip O'Carroll's Newport Beach office for their first ketamine treatment are in pain and often lost. They have visited other doctors, tried other solutions and are ready for what is considered a ...
Oct 5, 2022
0
12
A much-debated drug for Lou Gehrig's disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.
Sep 30, 2022
0
8
